SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001418
Filing Date
2021-08-13
Accepted
2021-08-13 10:52:56
Documents
88
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q me-20210630.htm   iXBRL 10-Q 2864031
2 EX-10.22 me-20210630ex10_22.htm EX-10.22 45945
3 EX-31.1 me-20210630ex31_1.htm EX-31.1 26137
4 EX-31.2 me-20210630ex31_2.htm EX-31.2 24087
5 EX-32.1 me-20210630ex32_1.htm EX-32.1 17462
6 EX-32.2 me-20210630ex32_2.htm EX-32.2 17470
  Complete submission text file 0000950170-21-001418.txt   11730549

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20210630.xsd EX-101.SCH 81234
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT me-20210630_def.xml EX-101.DEF 321205
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20210630_lab.xml EX-101.LAB 583316
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT me-20210630_cal.xml EX-101.CAL 42095
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20210630_pre.xml EX-101.PRE 462605
12 EXTRACTED XBRL INSTANCE DOCUMENT me-20210630_htm.xml XML 2466776
Mailing Address 223 NORTH MATHILDA AVENUE SUNNYVALE CA 94086
Business Address 223 NORTH MATHILDA AVENUE SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-39587 | Film No.: 211170402
SIC: 2834 Pharmaceutical Preparations